title: Progressive bilateral facial weakness.
authors.affiliation: Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
authors.forename: Christopher
authors.initials: C
authors.lastname: Carswell
authors.affiliation: Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
authors.forename: Luke C
authors.initials: LC
authors.lastname: Northey
authors.affiliation: Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
authors.forename: Leo
authors.initials: L
authors.lastname: Davies
authors.affiliation: Departments of Medicine and Physiology, Yong Loo Lin School of Medicine, National University of Singapore, #09-01 Neuroscience Research Centre, Centre for Translational Medicine, Singapore, Singapore.
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Yuki
authors.affiliation: Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia Brain & Mind Research Institute, University of Sydney, Camperdown, New South Wales, Australia.
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Kiernan
mesh_terms: D000368:Aged; D003937:Diagnosis, Differential; D005158:Facial Paralysis / Q000175:diagnosis / Q000209:etiology*; D020233:Gait Disorders, Neurologic / Q000150:complications; D020275:Guillain-Barre Syndrome / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D006181:H-Reflex; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D009460:Neurologic Examination; D010951:Plasma Exchange
chemical_list: D016756:Immunoglobulins, Intravenous
keywords: GANGLIOSIDE; GUILLAIN-BARRE SYNDROME